Skip to search formSkip to main contentSkip to account menu

Thomsen-Friedenreich antigen

Known as: 2-acetamido-2-deoxy-3-O-(beta--galactopyranosyl)-D-galactose, T-crypt antigen, beta-D-Gal(1-3)alpha-D-GalNAc 
A type 1 core O-glycan with potential immunotherapeutic property. Thomsen-Friedenreich (TF) antigen, a galactose disaccharide, is normally O-linked… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Antigens, Tumor-Associated, Carbohydrate
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Isolation and Characterization of Thomsen-Friedenreich-Specific Antibodies from Human Serum
The Thomsen-Friedenreich (TF) disaccharide, galactose (Gal)β1–3GalNAcα-, is a blood group-related oncofetal antigen with… 
Highly Cited
2001
Highly Cited
2001
Synthesis of beta-galactose-conjugated chlorins derived by enyne metathesis as galectin-specific photosensitizers for photodynamic therapy.
A first report on the synthesis and biological evaluation of the beta-galactose-conjugated purpurinimides (a class of chlorins… 
Highly Cited
2000
Highly Cited
2000
Thomsen‐Friedenreich antigen presents as a prognostic factor in colorectal carcinoma
Up to now, the expression of the tumor‐associated Thomsen‐Friedenreich (TF) antigen in colorectal carcinoma has not been… 
Highly Cited
2000
Highly Cited
2000
Clinical Comparison of Two Total Ankle Replacements
We compared the outcome of the cemented Thompson Parkridge Richards (TPR) ankle prosthesis with that of the cementless… 
Highly Cited
1993
Highly Cited
1993
Glycopeptides of biological interest: A challenge for chemical synthesis
Abstract 
1991
1991
Vapor phase hydrogen peroxide inhibits postharvest decay of table grapes
The potential use of vapor phase hydrogen peroxide (VPHP) to prevent decay caused by Botrytis cinerea Pers. ex Fr. in table… 
Highly Cited
1989
Highly Cited
1989
Monoclonal IgMs with anti-Gal(β1–3)GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins
Highly Cited
1988
Highly Cited
1988
Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients.
Paraffin-embedded tissue sections of primary tumors and lymph node metastases of 80 breast cancer patients were tested for the… 
Highly Cited
1981
Highly Cited
1981
Origin of Anti‐Thomsen‐Friedenreich (T) and Tn Agglutinins in Man and in White Leghorn Chicks
Summary. Interest in anti‐Thomsen‐Friedenreich (T) antibodies has increased because of their significance in detection of and… 
1981
1981
Use of a synthetic hapten in the demonstration of the Thomsen-Friedenreich (T) antigen on neuraminidase-treated human red blood cells and lymphocytes.
Using an artificial T hapten, we have confirmed that human sera contain agglutinins for neuraminidase-treated red blood cells (N… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)